Sanuwave Health Reports Record Q1 2025 Growth

SANUWAVE Health Inc. ( (SNWV) ) has released its Q1 earnings. Here is a breakdown of the information SANUWAVE Health Inc. presented to its investors.

Sanuwave Health Inc., a company specializing in next-generation FDA-approved wound care products, has reported its financial results for the first quarter of 2025, showcasing significant growth. The company achieved record Q1 revenues of $9.3 million, marking a 61% increase from the previous year, and a gross margin improvement to 79%. Operating income rose to $1.0 million, a notable increase from a loss in the same quarter last year, driven by strategic efforts to enhance profitability and manage expenses. Despite these positive results, the company reported a net loss of $5.7 million, primarily due to changes in the fair value of derivative liabilities. Sanuwave’s UltraMist® systems sales saw a substantial increase, contributing significantly to the company’s revenue growth. Looking ahead, Sanuwave remains optimistic about its growth trajectory, forecasting a 40-50% revenue increase for the second quarter of 2025 compared to the same period in 2024, and maintaining its full-year revenue guidance. The company is focused on expanding its commercial operations and maintaining profitability as it continues to pursue larger customer engagements.